Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Marini

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 22, 2014
Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipientsA M Huang, B L Marini, D Frame, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 2, 2016
Minimizing waste during preparation of blinatumomab infusionsBernard L Marini, Andrew R Wechter, Patrick W Burke, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2018
Successful use of cytarabine and bendamustine in a patient with mantle cell lymphoma and acute renal failure using intermittent hemodialysis: A case reportMatthew Ettleson, Kale S Bongers, Kaitlyn Vitale, et al.
Annals of Hematology|June 9, 2023
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphomaVictoria R Nachar, Anthony J Perissinotti, Bernard L Marini, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2014
Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?Bernard L Marini, Anthony J Perissinotti, Angela M Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 4, 2022
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged NeutropeniaWilliam Alegria, Bernard L Marini, Kevin Sellery Gregg, et al.
American Journal of Hematology|May 9, 2001
Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysisL Ginaldi, M De Martinis, A D'Ostilio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2015
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropeniaBernard L Marini, Shannon M Hough, Kevin S Gregg, et al.
Leukemia Research|November 6, 2017
Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessmentVictoria R Nachar, Anthony J Perissinotti, Gianni B Scappaticci, et al.
Anticancer Research|September 1, 1994
Direct antiproliferative effect of triptorelin on human breast cancer cellsL Marini, F Iacopino, G Schinzari, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 22, 2014
Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipientsA M Huang, B L Marini, D Frame, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 2, 2016
Minimizing waste during preparation of blinatumomab infusionsBernard L Marini, Andrew R Wechter, Patrick W Burke, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2018
Successful use of cytarabine and bendamustine in a patient with mantle cell lymphoma and acute renal failure using intermittent hemodialysis: A case reportMatthew Ettleson, Kale S Bongers, Kaitlyn Vitale, et al.
Annals of Hematology|June 9, 2023
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphomaVictoria R Nachar, Anthony J Perissinotti, Bernard L Marini, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2014
Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?Bernard L Marini, Anthony J Perissinotti, Angela M Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 4, 2022
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged NeutropeniaWilliam Alegria, Bernard L Marini, Kevin Sellery Gregg, et al.
American Journal of Hematology|May 9, 2001
Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysisL Ginaldi, M De Martinis, A D'Ostilio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2015
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropeniaBernard L Marini, Shannon M Hough, Kevin S Gregg, et al.
Leukemia Research|November 6, 2017
Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessmentVictoria R Nachar, Anthony J Perissinotti, Gianni B Scappaticci, et al.
Anticancer Research|September 1, 1994
Direct antiproliferative effect of triptorelin on human breast cancer cellsL Marini, F Iacopino, G Schinzari, et al.
Pageof 19